14-74357767-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_018228.3(VRTN):c.984C>T(p.Gly328=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00104 in 1,613,010 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0012 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 20 hom. )
Consequence
VRTN
NM_018228.3 synonymous
NM_018228.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.33
Genes affected
VRTN (HGNC:20223): (vertebrae development associated) Predicted to enable sequence-specific DNA binding activity and transposase activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in chromatin. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 14-74357767-C-T is Benign according to our data. Variant chr14-74357767-C-T is described in ClinVar as [Benign]. Clinvar id is 791039.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.33 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00102 (1492/1460642) while in subpopulation AMR AF= 0.0206 (922/44722). AF 95% confidence interval is 0.0195. There are 20 homozygotes in gnomad4_exome. There are 647 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VRTN | NM_018228.3 | c.984C>T | p.Gly328= | synonymous_variant | 2/2 | ENST00000256362.5 | NP_060698.2 | |
VRTN | XM_011536911.3 | c.984C>T | p.Gly328= | synonymous_variant | 3/3 | XP_011535213.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VRTN | ENST00000256362.5 | c.984C>T | p.Gly328= | synonymous_variant | 2/2 | 1 | NM_018228.3 | ENSP00000256362 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00120 AC: 183AN: 152250Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
183
AN:
152250
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00378 AC: 945AN: 250078Hom.: 13 AF XY: 0.00289 AC XY: 391AN XY: 135390
GnomAD3 exomes
AF:
AC:
945
AN:
250078
Hom.:
AF XY:
AC XY:
391
AN XY:
135390
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00102 AC: 1492AN: 1460642Hom.: 20 Cov.: 31 AF XY: 0.000890 AC XY: 647AN XY: 726698
GnomAD4 exome
AF:
AC:
1492
AN:
1460642
Hom.:
Cov.:
31
AF XY:
AC XY:
647
AN XY:
726698
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00119 AC: 182AN: 152368Hom.: 5 Cov.: 32 AF XY: 0.00133 AC XY: 99AN XY: 74504
GnomAD4 genome
AF:
AC:
182
AN:
152368
Hom.:
Cov.:
32
AF XY:
AC XY:
99
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at